Assignee
NOSTER INC
JP·6 granted patents·1 pending application·0 citations·filing 2017–2022
Top patents by PatentIndex Score
7 records- 0178US12491173B2Metabolism-improving agent comprising rare fatty acidNOSTER INC·Filed 2021·Granted Dec 9, 2025·0 cites·18 claims
- 0264US12357601B2Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivativeNOSTER INC·Filed 2022·Granted Jul 15, 2025·0 cites·9 claims
- 0357US11337947B2Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivativeNOSTER INC·Filed 2018·Granted May 24, 2022·0 cites·8 claims
- 0455US12391968B2Production method for rare fatty acid using novel enzyme, and novel rare fatty acidNOSTER INC·Filed 2020·Granted Aug 19, 2025·0 cites·9 claims
- 0555US11730772B2Lipopolysaccharide-regulated enteric bacteria and use thereofNOSTER INC·Filed 2019·Granted Aug 22, 2023·0 cites·9 claims
- 0654US10792302B2Composition for preventing or treating metabolism disorders comprising leuconostoc mesenteroides-producing exopolysaccharide as active ingredientNOSTER INC·Filed 2017·Granted Oct 6, 2020·0 cites·4 claims
- 0741US2022367021A1Bacterial supplying systemNOSTER INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →